scholarly article | Q13442814 |
review article | Q7318358 |
P2093 | author name string | Carol Lee | |
Kirsten L. Johansen | |||
P2860 | cites work | Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People | Q24633789 |
The endocrine function of adipose tissue: an update | Q28305131 | ||
Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee | Q29619180 | ||
Association of body mass index with outcomes in patients with CKD. | Q30371128 | ||
Associations of body mass index and weight loss with mortality in transplant-waitlisted maintenance hemodialysis patients | Q30427552 | ||
Association between body composition and frailty among prevalent hemodialysis patients: a US Renal Data System special study | Q30683934 | ||
Associations of body size and body composition with functional ability and quality of life in hemodialysis patients. | Q33715821 | ||
Anabolic exercise in haemodialysis patients: a randomised controlled pilot study | Q34156946 | ||
Indices of relative weight and obesity | Q34215861 | ||
Comparative associations of muscle mass and muscle strength with mortality in dialysis patients. | Q34292906 | ||
Urinary creatinine excretion, bioelectrical impedance analysis, and clinical outcomes in patients with CKD: the CRIC study | Q34629756 | ||
Adolphe Quetelet (1796-1874)--the average man and indices of obesity | Q34692210 | ||
Sarcopenic obesity: a new category of obesity in the elderly | Q34768514 | ||
Association of frailty with body composition among patients on hemodialysis | Q35260720 | ||
Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia | Q36039024 | ||
Effect of oral anabolic steroid on muscle strength and muscle growth in hemodialysis patients | Q36583321 | ||
Waist circumference as a predictor of adiponectin levels in peritoneal dialysis patients: a 12-month follow-up study | Q36686006 | ||
Obesity and body composition for transplant wait-list candidacy--challenging or maintaining the BMI limits? | Q36791910 | ||
Sarcopenic obesity: definition, cause and consequences | Q37078687 | ||
Influence of body mass index on the association of weight changes with mortality in hemodialysis patients | Q37212390 | ||
Frailty and protein-energy wasting in elderly patients with end stage kidney disease | Q38069572 | ||
The adipose tissue as an endocrine organ | Q38078542 | ||
Body mass index and mortality in kidney transplant recipients: a systematic review and meta-analysis | Q38262348 | ||
Effects of resistance exercise training and nandrolone decanoate on body composition and muscle function among patients who receive hemodialysis: A randomized, controlled trial. | Q38467489 | ||
Body composition monitor assessing malnutrition in the hemodialysis population independently predicts mortality | Q39233810 | ||
Visceral obesity assessed by computed tomography predicts cardiovascular events in chronic kidney disease patients | Q39578502 | ||
Positive association of vigorous and moderate physical activity volumes with skeletal muscle mass but not bone density or metabolism markers in hemodialysis patients | Q40171095 | ||
Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients | Q40351722 | ||
Sarcopenia and age-related changes in body composition and functional capacity | Q40873939 | ||
Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial | Q41646726 | ||
Subclinical versus overt obesity in dialysis patients: more than meets the eye. | Q42241922 | ||
Morbid obesity is not an independent predictor of graft failure or patient mortality after kidney transplantation | Q42620239 | ||
Misclassification of obesity in CKD: appearances are deceptive | Q43054834 | ||
A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease | Q43442519 | ||
Visceral fat and coronary artery calcification in patients with chronic kidney disease | Q43541949 | ||
Plasma adiponectin levels for prediction of cardiovascular risk among hemodialysis patients | Q43769000 | ||
Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease | Q43829986 | ||
Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients | Q43931509 | ||
Muscle atrophy in patients receiving hemodialysis: effects on muscle strength, muscle quality, and physical function | Q44282602 | ||
Kidney function and sarcopenia in the United States general population: NHANES III. | Q44325706 | ||
Limb/trunk lean mass ratio as a risk factor for mortality in peritoneal dialysis patients | Q45835376 | ||
Association of body size with outcomes among patients beginning dialysis. | Q46027289 | ||
Obesity, regional body fat distribution, and the metabolic syndrome in older men and women | Q46433125 | ||
Association of serum adiponectin levels with all-cause mortality in hemodialysis patients | Q46698525 | ||
Body weight-for-height relationships predict mortality in maintenance hemodialysis patients | Q46899223 | ||
Association of serum total testosterone concentration with skeletal muscle mass in men under hemodialysis | Q47693568 | ||
Simple nutritional indicators as independent predictors of mortality in hemodialysis patients | Q47957844 | ||
Serum testosterone levels and clinical outcomes in male hemodialysis patients | Q48197026 | ||
Prevalence of and factors associated with sarcopenia in elderly patients with end-stage renal disease | Q48480311 | ||
Waist circumference modifies the relationship between the adipose tissue cytokines leptin and adiponectin and all-cause and cardiovascular mortality in haemodialysis patients. | Q50787029 | ||
Progressive exercise for anabolism in kidney disease (PEAK): a randomized, controlled trial of resistance training during hemodialysis. | Q51918236 | ||
Effect of resistance exercise during hemodialysis on physical function and quality of life: randomized controlled trial. | Q53103470 | ||
Increased visceral adiposity is associated with coronary artery calcification in male patients with chronic kidney disease. | Q53115545 | ||
Randomized controlled trial to evaluate the impact of aerobic exercise on visceral fat in overweight chronic kidney disease patients | Q57423439 | ||
Effects of a six-month intradialytic physical ACTIvity program and adequate NUTritional support on protein-energy wasting, physical functioning and quality of life in chronic hemodialysis patients: ACTINUT study protocol for a randomised controlled t | Q59823362 | ||
Increasing Body Mass Index and Obesity in the Incident ESRD Population | Q60777261 | ||
Endogenous Testosterone, Muscle Strength, and Fat-Free Mass in Men With Chronic Kidney Disease | Q61927848 | ||
Nandrolone decanoate as anabolic therapy in chronic kidney disease: a randomized phase II dose-finding study | Q80376283 | ||
Prevalence of sarcopenia in elderly maintenance hemodialysis patients: the impact of different diagnostic criteria | Q85319983 | ||
Resistance exercise training does not affect plasma irisin levels of hemodialysis patients | Q85649402 | ||
Benefits of exercise training during hemodialysis sessions: a prospective cohort study | Q86583986 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | chronic renal insufficiency | Q736715 |
P304 | page(s) | 268-75 | |
P577 | publication date | 2015-05-01 | |
P1433 | published in | Current Opinion in Nephrology and Hypertension | Q15756282 |
P1476 | title | Body composition in chronic kidney disease | |
P478 | volume | 24 |
Q92443997 | Associations between severe co-morbidity and muscle measures in advanced non-small cell lung cancer patients |
Q60729320 | Associations of pre-existing co-morbidities with skeletal muscle mass and radiodensity in patients with non-metastatic colorectal cancer |
Q49985968 | CX3CL1/CX3CR1 axis, as The Therapeutic Potential In Renal Diseases: Friend Or Foe? |
Q96132970 | Chronic Kidney Disease Modifies The Relationship Between Body Fat Distribution and Blood Pressure: A Cross-Sectional Analysis |
Q88989692 | Frailty, body composition and the risk of mortality in incident hemodialysis patients: the Predictors of Arrhythmic and Cardiovascular Risk in End Stage Renal Disease study |
Q47550288 | Gender-specific associations of skeletal muscle mass and arterial stiffness among peritoneal dialysis patients. |
Q40563733 | NF-κB expression and its association with nutritional status in hemodialysis patients |
Q90685923 | Preventive Nephrology: The Role of Obesity in Different Stages of Chronic Kidney Disease |
Q49358692 | The Saudi Diabetic Kidney Disease study (Saudi-DKD): clinical characteristics and biochemical parameters. |
Q64240706 | The associations of fat tissue and muscle mass indices with all-cause mortality in patients undergoing hemodialysis |
Q37148305 | The influence of body composition on renal function in patients with coronary artery disease and its prognostic significance: a retrospective cohort study |
Q47389899 | Unacylated ghrelin and obestatin: promising biomarkers of protein energy wasting in children with chronic kidney disease. |
Q86617372 | Vitamin D status, body composition and glycemic control in an ambulatory population with diabetes and chronic kidney disease |
Q47559113 | Volume Estimates in Chronic Hemodialysis Patients by the Watson Equation and Bioimpedance Spectroscopy and the Impact on the Kt/Vurea calculation |
Q87999931 | [Decline in renal function in old age : Part of physiological aging versus age-related disease] |
Search more.